Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Hikma Pharmaceuticals Plc
(OP:
HKMPY
)
68.20
USD
UNCHANGED
Streaming Delayed Price
Updated: 1:55 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Hikma Pharmaceuticals Plc
< Previous
1
2
Next >
Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report
January 13, 2021
Improved rating elevates Hikma to global leadership position
From
PR Newswire
Hikma launches generic Advair Diskus® following FDA approval
December 17, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it has received FDA approval for and launched its generic version of GlaxoSmithKline's Advair Diskus®1...
From
PR Newswire
Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum™ in the Middle East and North Africa
December 01, 2020
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Hikma Pharmaceuticals, a multi-national...
From
Business Wire News Releases
Hikma and Arecor Expand Collaboration
October 20, 2020
From
GlobeNewswire News Releases
Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
October 20, 2020
Adds ready-to-administer injectable product to companies' existing partnership
From
PR Newswire
Hikma receives favourable court ruling for its generic Vascepa®
September 03, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the...
From
PR Newswire
Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership
August 26, 2020
Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD. The round was led by MEDTEQ,...
From
PR Newswire
Twitter Looks At Crashing Microsoft’s TikTok Party
August 10, 2020
Over the weekend it was reported that social media firm Twitter has held initial talks about a possible deal to acquire TikTok’s US operation, something that Microsoft has spent weeks negotiating with...
Tags
Currencies/Forex
Energy
Consumer Goods
From
Blogs - TalkMarkets
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020
Receives first Competitive Generic Therapy Exclusivity from FDA
From
PR Newswire
FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules
May 22, 2020
The arrival of a generic version of Vascepa will be bad news for the company.
Tags
AMRN
Market News
HKMPY
From
Motley Fool
Hikma receives FDA approval for its generic Vascepa®
May 22, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the...
From
PR Newswire
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
May 12, 2020
Sedative for patients on ventilators currently in short supply in the US
From
PR Newswire
Hikma launches employee matching donation campaign to support local US food banks and pantries
May 11, 2020
Campaign will help address significant increase in demand caused by COVID-19 related job losses and furloughs
From
PR Newswire
Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain diseases with up to 94% accuracy
May 04, 2020
Hikma Pharmaceuticals PLC announces that its venture capital arm, Hikma Ventures has invested in Altoida, Inc. following the company's $6.3 million Series A round in 2019.
From
PR Newswire
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
May 04, 2020
Altoida's FDA-cleared and CE Mark-approved medical device and brain health data platform detects Alzheimer's Disease (AD) up to ten years prior to onset - with up to 94% accuracy
From
PR Newswire
Why Did Amarin's Stock Fall Off a Cliff?
April 02, 2020
Amarin's stock dropped 70% after its patent for Vascepa was invalidated by a federal judge.
Tags
AMRN
Market News
HKMPY
From
Motley Fool
Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa
March 31, 2020
The shares of Amarin Corporation plc (NASDAQ: AMRN) tanked in the after-hours session on Monday as thecourt ruled against its ...
Tags
General
GSK
News
From
Benzinga
Hikma confirms favourable ruling in generic Vascepa® patent suit
March 31, 2020
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, today confirms that the United States District Court for the District of Nevada has ruled that Hikma's...
From
PR Newswire
Shares of Amarin Down 68% After Losing a Patent Lawsuit for Vascepa
March 30, 2020
Judge rules that the patents were obvious.
Tags
HKMPY
AMRN
GSK
From
Motley Fool
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
February 27, 2020
Builds on Hikma's leading position in nasal sprays and strong specialty salesforce
From
PR Newswire
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Using Arestat™ Technology
January 09, 2020
Product designed to provide safer, more immediate treatment option for patients
From
GlobeNewswire News Releases
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
January 09, 2020
Product designed to provide safer, more immediate treatment option for patients
From
PR Newswire
Up 25% in 2 Months, This Healthcare Stock Could Climb Even Higher
December 18, 2019
Here is why Jazz Pharmaceuticals could survive the threat from generics for its top-selling product.
Tags
JAZZ
Market News
HKMPY
From
Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
December 10, 2019
During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was ...
Tags
FSUGY
XENE
BRBR
From
Benzinga
Civica Rx and Hikma Announce Shipments of Heparin and Seven Other Essential Injectable Medicines
December 10, 2019
Civica Rx (Civica, Inc.) and Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic...
From
Business Wire News Releases
Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments
November 18, 2019
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) announces that its venture capital arm, Hikma Ventures has led a CAD 5.6 million...
From
PR Newswire
Hikma launches prefilled syringes in the US
September 17, 2019
Heparin Sodium Injection in a ready-to-use syringe is the first product using Hikma's new injectable manufacturing capability
From
PR Newswire
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
July 23, 2019
Partnership will supply 14 essential medicines to US hospitals and patients
From
PR Newswire
Hikma Ventures participates in $11 million funding round for Pillo Health
May 30, 2019
Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) today announced its venture capital arm Hikma Ventures has participated in an...
From
PR Newswire
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home
May 29, 2019
Pillo Health, a Boston-based technology company improving longevity and quality of life for patients managing their health at home, today announced that is has secured $11 million in funding from...
From
PR Newswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.